Long-term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension

Yuichi Tamura, Asuka Furukawa, Yudai Tamura, Kenta Yamada, Hirohisa Taniguchi, Keiichi Fukuda, Akio Kawamura, Toru Satoh

研究成果: Article査読

抄録

There was no structured method for safely transition from parenteral prostanoids to oral medication. We enrolled 37 idiopathic/hereditary pulmonary arterial hypertension patients receiving triple combination therapy including parenteral prostanoids into structured transition program to oral selexipag. Four (10.8%) patients successfully transitioned under the protocol, and all of them presented long-term safety.

本文言語English
論文番号e12058
ジャーナルPulmonary Circulation
12
1
DOI
出版ステータスPublished - 2022 1月

ASJC Scopus subject areas

  • 呼吸器内科

フィンガープリント

「Long-term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル